Compare IRTC & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRTC | KVYO |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2016 | 2023 |
| Metric | IRTC | KVYO |
|---|---|---|
| Price | $114.02 | $19.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 22 |
| Target Price | ★ $207.54 | $35.55 |
| AVG Volume (30 Days) | 569.7K | ★ 3.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.71 | 35.29 |
| EPS | N/A | ★ N/A |
| Revenue | $747,138,000.00 | ★ $1,234,019,000.00 |
| Revenue This Year | $19.58 | $24.47 |
| Revenue Next Year | $15.95 | $19.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 26.24 | ★ 31.63 |
| 52 Week Low | $92.52 | $15.53 |
| 52 Week High | $210.01 | $36.76 |
| Indicator | IRTC | KVYO |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | 47.28 |
| Support Level | $112.31 | $15.53 |
| Resistance Level | $184.04 | $21.83 |
| Average True Range (ATR) | 4.33 | 1.01 |
| MACD | 1.37 | 0.10 |
| Stochastic Oscillator | 27.13 | 48.38 |
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.